Case Challenge

Management of a Treatment-Naive, HBeAg-Positive, Asian American Patient

Source: Case Debates With the Experts: Applying the Updated Practice Guidelines to the Management of Hepatitis B

Management of a Treatment-Naive, HBeAg-Positive, Asian American Patient

Program Director: Norah Terrault, MD, MPH

Faculty:

Jules L. Dienstag, MD

CREDIT INFORMATION

Release Date: November 03, 2007

Expiration Date: November 02, 2008

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Recount the treatment criteria for determining when to begin therapy in an HBeAg-positive patient
Discuss the clinical data regarding the agents available to treat chronic hepatitis B
Summarize factors that determine how long one should continue therapy after seroconversion in HBeAg-positive patients

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.